Publications

Keep up-to-date on the latest work from our in-house experts. We produce a wide range of publications from whitepapers, roadmaps, scientific posters and presentations. Contact us for more information on any of the topics below.

23rd January 2025UK GMO CU Authorisation Procedures for Clinical Trial Products January 2025 2nd December 2024Building the digital infrastructure for capturing patient outcomes data from routine clinical practice: The AIM4ALL initiative in Scotland 18th November 2024ATMP clinical trials in the UK 4th April 2023Adeno-associated virus production platform performance for 2L and 50L scales 13th January 2023ATTC Bridging CAR T Patient Referrals Executive Summary 24th November 2022Healthcare system readiness for the adoption of advanced therapies: learnings from the introduction of CAR T cell therapies in the UK 9th December 2021CGT Catapult Guidance on the development and marketing of ATMPs in the UK and EU at this position post-BREXIT 27th May 2021Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP 23rd March 2020Optimising the design of clinical trials for advanced therapies workshop report 27th February 2020Process Analytical Technology Strategy For Lentiviral Manufacture 2nd December 2019The need for development of new analytical solutions for quality testing of ATMPs throughout manufacture 8th November 2019Safety of Cell Therapy Products: In vitro Methods to Assess the Tumorigenicity of Human Cell Based Therapeutic Products 1st November 2019Development of a scalable platform for AAV manufacturing 1st November 2019Single cell analysis of lentiviral integration to support ex-vivo gene modified cell therapy development 28th October 2019Cell and Gene Therapy Catapult manufacturing centre - one year in operation 29th May 2019Increasing lentiviral transduction efficiency 22nd May 2019Automated analysis of morphology attributes of PSCs in adherent and suspension culture 22nd May 2019Development of iPSC processing platforms 22nd May 2019Development of an analytical strategy to ensure production efficiently and consistency of a WT1-TCR immunotherapy 27th March 2019The potential of cell and gene therapies 10th December 2018Logistics by design: a framework for advanced therapy developers to create optimal Logistics Platforms 29th October 2018ATTCs, clinical infrastructure requirements and adoption of ATMPs workshop 1st October 2018Apprenticeships in advance therapies - managers checklist 27th September 2018Apprenticeships in advance therapies - guidance booklet 4th September 2018Potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US 30th July 2018Proposed Solutions to Further Improve the Regulatory Landscape for ATMPS in Europe 16th July 2018Addressing the challenges of expansion of hPSCs 14th May 2018T-cell therapy bioprocessing 2nd May 2018Raman spectroscopy as a process analytical technology 24th January 2018Anticipating the clinical adoption of regenerative medicine 25th October 2017Cell and Gene Therapy Catapult manufacturing centre 31st July 2017Annuity payments can increase patient access to innovative cell and gene therapies 15th June 2017Expansion of human pluripotent stem cells in stirred tank reactors 15th June 2017Development of a cell therapy PAT strategy based on multiparametric product characterisation 1st June 2017Single cell analysis of viral copy number 9th May 2017Screening of defined medium for the adherent expansion of an induced pluripotent stem cell line 3rd May 2017Development of a novel potency assay 3rd May 2017Development of processing platforms for industrial manufacture 3rd May 2017CFD simulation of small-scale single-use stirred tank bioreactors 3rd May 2017Characterisation of a dynamic modular automated system 3rd May 2017A strategy for robust implementation of process analytical technologies 3rd May 2017Transfer and optimisation of ATMP manufacturing 3rd May 2017Closed expansion and harvest of pluripotent stem cells 3rd May 2017Developing integrated platform processing options 3rd May 2017Development of an identity assay for in process and release testing 21st April 2017Dynamic array based method for high throughput and flexible assessment of pluripotency in PSCs 16th January 2017Development of a cost efficient platform for the industrial manufacturing of pluripotent stem cell derived products for cell therapy 29th November 2016Improving Expansion of Pluripotent Stem Cells in Stirred Tank Reactors 25th October 2016Comparability: manufacturing, characterization and controls 14th October 2016Evaluation of a novel bench-top stirred-tank bioreactor for process development of autologous T-cell therapies 10th October 2016The Impact of Thaw Rate on the Recovery and Proliferation of MSCs and T cells 23rd September 2016Cell History File Template 23rd September 2016Early Access to Medicines Scheme 23rd September 2016Genetically Modified T Cell Therapies for Cancer - Basic Facts